These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 121486

  • 1. [Coadjuvant action of chemotherapy and immunotherapy in the carcinoma of the bladder].
    Rodrigues-Netto Júnior N, Napoli F, Lemos GC.
    Rev Paul Med; 1979; 94(3-4):51-3. PubMed ID: 121486
    [No Abstract] [Full Text] [Related]

  • 2. [Comparative study of treatments of bladder carcinoma: TUR, thiotepa or BCG].
    Rodrigues Netto Júnior N, Caserta Lemos G.
    Arch Esp Urol; 1981; 34(5):369-74. PubMed ID: 6800309
    [No Abstract] [Full Text] [Related]

  • 3. BCG versus thiotepa in non-CIS, stage Ta, T1 bladder cancer: rationale and design of ECOG trial.
    Fisher HA.
    Prog Clin Biol Res; 1989; 310():275-83. PubMed ID: 2505271
    [No Abstract] [Full Text] [Related]

  • 4. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA, Jimenez León J, Martinez-Pineiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P.
    Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
    [Abstract] [Full Text] [Related]

  • 5. [Adjuvant local BCG-immunotherapy in patients with urothel cancer of the bladder (author's transl)].
    Flamm J, Grof F.
    Wien Med Wochenschr; 1981 Oct 31; 131(20):501-6. PubMed ID: 7314632
    [Abstract] [Full Text] [Related]

  • 6. [Clinical experience with BCG immune prevention in superficial bladder cancer].
    Bach D, Romics I, Rüssel C.
    Urologe A; 1992 Sep 31; 31(5):296-301. PubMed ID: 1302409
    [Abstract] [Full Text] [Related]

  • 7. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, Sarosdy MF, Bohl RD, Grossman HB, Beck TM, Leimert JT, Crawford ED.
    J Urol; 2000 Apr 31; 163(4):1124-9. PubMed ID: 10737480
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin.
    Volkmer BG, Gschwend JE, Maier SH, Seidl-Schlick EM, Bach D, Romics I.
    J Urol; 2003 Mar 31; 169(3):931-4; discussion 934-5. PubMed ID: 12576815
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M.
    Duodecim; 2002 Mar 31; 118(9):903-9. PubMed ID: 12238168
    [No Abstract] [Full Text] [Related]

  • 16. Superficial bladder disease: case studies and therapeutic advances.
    Soloway MS, Droller MJ, Flanigan RC, Nseyo UO.
    Urology; 1992 Dec 31; 40(6 Suppl):11-22. PubMed ID: 1466118
    [No Abstract] [Full Text] [Related]

  • 17. Immunoprophylaxis of superficial bladder cancer: a prospective and randomized comparison of oral versus intravesical Bacillus Calmette-Guerin.
    Netto Júnior NR, Levi d'Ancona CA, Claro JF, Ilari O.
    Arch Esp Urol; 1991 Oct 31; 44(8):1025-8. PubMed ID: 1796850
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin.
    Brake M, Loertzer H, Horsch R, Keller H.
    J Urol; 2000 Jun 31; 163(6):1697-701. PubMed ID: 10799163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.